Exozymes sets Nov. 13, 2026 shareholder meeting
EXOZYMES INC. set the date, record date and expected mailing date for its 2026 annual shareholder meeting.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
8-K
Rhea-AI Filing Summary
EXOZYMES INC. (EXOZ) announced key details for its 2026 annual meeting of shareholders. The company plans to hold the annual meeting on November 13, 2026.
Shareholders of record as of September 15, 2026 will be entitled to vote, and the company plans to distribute its proxy statement and proxy around September 28, 2026.
8-K Event Classification
2 items: 8.01, 9.01
2 items
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Key Figures
2026 annual meeting date: November 13, 2026
Record date: September 15, 2026
Planned proxy mailing date: On or about September 28, 2026
+2 more
5 metrics
2026 annual meeting date
November 13, 2026
Scheduled date for EXOZYMES INC. annual meeting of shareholders
Record date
September 15, 2026
Shareholders of record on this date may vote at the 2026 annual meeting
Planned proxy mailing date
On or about September 28, 2026
Planned distribution timing for proxy statement and proxy materials
Trading symbol
EXOZ
Ticker for EXOZYMES INC. common stock
Exchange listing
Nasdaq Capital Market
Market where EXOZ common stock is listed
Key Terms
record date, proxy statement, Nasdaq Capital Market
3 terms
record date financial
"The record date for the meeting was September 15, 2026"
The record date is the specific day when a company determines which shareholders are eligible to receive a dividend or participate in an upcoming vote. It’s like a cutoff date; if you own the stock on that day, you get the benefits or voting rights. This date matters because it decides who qualifies for certain company benefits.
proxy statement regulatory
"plans to distribute its proxy statement and proxy to the shareholders"
A proxy statement is a document companies send to shareholders ahead of a meeting that lays out the items up for a vote—like who will sit on the board, executive pay, and major corporate decisions—and provides background so shareholders can decide how to cast their votes or appoint someone to vote for them. Think of it as an agenda plus a ballot and briefing notes, important because the outcomes can change control, strategy, and value.
Nasdaq Capital Market market
"Common Stock | EXOZ | The Nasdaq Stock Market LLC (Nasdaq Capital Market)"
The Nasdaq Capital Market is a platform where smaller, emerging companies can list their shares for trading by investors. It provides these companies with access to funding and visibility, helping them grow, much like a local marketplace where new vendors can introduce their products to potential customers. For investors, it offers opportunities to discover early-stage companies with growth potential.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
When will EXOZYMES INC. (EXOZ) hold its 2026 annual meeting?
EXOZYMES INC. plans to hold its 2026 annual meeting on November 13, 2026. The company disclosed this timing under an Other Events item related to annual meeting arrangements.
What is the record date for EXOZYMES INC. (EXOZ) 2026 annual meeting?
The record date for EXOZYMES INC.’s 2026 annual meeting is September 15, 2026. Shareholders of record on that date will be entitled to receive the proxy materials and vote at the meeting.
When will EXOZYMES INC. (EXOZ) mail its 2026 proxy statement and proxy?
EXOZYMES INC. plans to distribute its proxy statement and proxy to shareholders on or about September 28, 2026. These materials will provide details on meeting matters and voting procedures.
Where is EXOZYMES INC. (EXOZ) headquartered according to this filing?
EXOZYMES INC. lists its principal executive offices at 750 Royal Oaks Drive, Suite 106, Monrovia, CA 91016, and provides a main telephone number of (626) 415-1488.
On which exchange is EXOZYMES INC. (EXOZ) common stock listed?
EXOZYMES INC.’s common stock, trading under the symbol EXOZ, is listed on The Nasdaq Stock Market LLC (Nasdaq Capital Market).
AI-generated analysis. How Rhea-AI works. Not financial advice.
